Naloxone topical - Elorac

Drug Profile

Naloxone topical - Elorac

Alternative Names: E-0316; Naloxone hydrochloride dehydrate lotion

Latest Information Update: 28 Jun 2016

Price : $50

At a glance

  • Originator Elorac
  • Class Antidotes; Morphinans; Small molecules
  • Mechanism of Action Opioid mu receptor antagonists; Opioid receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pruritus
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    Pruritus
  • New Molecular Entity No

Highest Development Phases

  • Phase III Pruritus

Most Recent Events

  • 22 Jun 2016 Elorac plans a phase III trial for Pruritus in USA (Topical) (NCT02811783)
  • 14 Jan 2015 Phase-III clinical trials in Pruritus in USA (Topical)
  • 12 Apr 2013 Naloxone topical - Elorac receives Fast Track designation for Pruritus [Topical,Lotion] in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top